PlumX Metrics
Embed PlumX Metrics

Capacity planning under clinical trials uncertainty in continuous pharmaceutical manufacturing, 2: Solution method

Industrial and Engineering Chemistry Research, ISSN: 0888-5885, Vol: 51, Issue: 42, Page: 13703-13711
2012
  • 19
    Citations
  • 0
    Usage
  • 32
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    19
    • Citation Indexes
      19
  • Captures
    32

Article Description

In Part 1 of this paper, we presented a scenario-based multiperiod mixed-integer linear programming (MILP) formulation for a capacity planning problem in continuous pharmaceutical manufacturing under clinical trials uncertainty. The number of scenarios and, thus, the formulation size grows exponentially with the number of products. The model size easily becomes intractable for conventional algorithms for more than 8 products. However, industrial-scale problems often involve 10 or more products, and thus a scalable solution algorithm is essential to solve such large-scale problems in reasonable times. In this part of the paper, we develop a rigorous decomposition strategy that exploits the underlying problem structure. We demonstrate the effectiveness of the proposed algorithm using several examples containing up to 16 potential products and over 65 000 scenarios. With the proposed decomposition algorithm, the solution time scales linearly with the number of scenarios, whereby a 16-product example with over 65 million binary variables, nearly 240 million continuous variables, and over 250 million constraints was solved in less than 6 h of solver time. © 2012 American Chemical Society.

Bibliographic Details

Sundaramoorthy, Arul; Li, Xiang; Evans, James M. B.; Barton, Paul I.

American Chemical Society (ACS)

Chemistry; Chemical Engineering; Engineering

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know